Leuprorelin acetate (Prostap DCS) accepted for use within NHS Scotland for advanced breast cancer

Leuprorelin offers an additional adjuvant treatment choice in pre- and perimenopausal women with advanced breast cancer suitable for hormonal manipulation.

Scottish Medicines Consortium